Real World Effectiveness of Eptinezumab in Participants With Migraine
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine how eptinezumab compares to other advanced preventive
medications in a real-world community setting in adult participants with episodic migraine
(EM) or chronic migraine (CM). These objectives include exploring the comparative
effectiveness on patient reported outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A Erenumab